| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KANK1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | XAGE5 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | CSE1L | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | GPR132 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | SEMG1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | SNX9 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | RGAG1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | ADCY4 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | EMC1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | RELL1 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
